Marksans Pharma touches the roof on BSE

23 Jul 2013 Evaluate

Marksans Pharma is locked at its upper circuit limit of at Rs. 9.81, up by 0.46 points or 4.92% from its previous closing of Rs. 9.35 on the BSE.

The scrip opened at Rs. 9.69 and has touched a high and low of Rs. 9.81 and Rs. 9.69 respectively. So far 386057 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 11.57 on 12-Jul-2013 and a 52 week low of Rs. 1.39 on 04-Sep-2012.

Last one week high and low of the scrip stood at Rs. 9.54 and Rs. 8.20 respectively. The current market cap of the company is Rs. 377.99 crore.

The promoters holding in the company stood at 51.21% while Institutions and Non-Institutions held 0.29% and 48.50% respectively.

Marksans Pharma has been de-registered from the purview of SICA and is no longer in Board for Industrial and Financial Reconstruction (BIFR) as per the directions of the BIFR in its hearing held on July 17, 2013. The summary record of proceedings of the hearing is awaited.

Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.

 

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×